Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 2
2019 1
2020 1
2021 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
The presence of additional cytogenetic aberrations in chronic myeloid leukemia cells at the time of diagnosis or their appearance on tyrosine kinase inhibitor therapy predicts the imatinib treatment failure.
Ratajczak B, Przybyłowicz-Chalecka A, Czerwińska-Rybak J, Kanduła Z, Ustaszewski A, Gil L, Lewandowski K, Jarmuż-Szymczak M. Ratajczak B, et al. Among authors: czerwinska rybak j. Leuk Res. 2023 Sep;132:107349. doi: 10.1016/j.leukres.2023.107349. Epub 2023 Jun 28. Leuk Res. 2023. PMID: 37393627 Free article.
Defining the mutational profile of lower-risk myelodysplastic neoplasm patients with respect to disease progression using next-generation sequencing and pyrosequencing.
Adamska M, Kowal-Wiśniewska E, Czerwińska-Rybak J, Kiwerska K, Barańska M, Gronowska W, Loba J, Brzeźniakiewicz-Janus K, Wasilewska E, Łanocha A, Jarmuż-Szymczak M, Gil L. Adamska M, et al. Among authors: czerwinska rybak j. Contemp Oncol (Pozn). 2023;27(4):269-279. doi: 10.5114/wo.2023.135365. Epub 2024 Feb 17. Contemp Oncol (Pozn). 2023. PMID: 38405213 Free PMC article.
Characterization and significance of the Philadelphia negative/BCR-ABL1 positive rearrangement or masked Philadelphia translocation in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single-center study.
Ratajczak B, Gniot M, Przybylowicz-Chalecka A, Czerwinska-Rybak J, Komarnicki M, Lewandowski K, Jarmuz-Szymczak M. Ratajczak B, et al. Among authors: czerwinska rybak j. Leuk Lymphoma. 2020 Jan;61(1):189-193. doi: 10.1080/10428194.2019.1648807. Epub 2019 Aug 7. Leuk Lymphoma. 2020. PMID: 31389273 No abstract available.
New genetic variants of TET2 and ASXL1 identified by next generation sequencing and pyrosequencing in a patient with MDS-RS-MLD and secondary acute myeloid leukemia.
Adamska MM, Kowal-Wiśniewska E, Kiwerska K, Ustaszewski A, Czerwińska-Rybak J, Kanduła Z, Wojtaszewska M, Barańska M, Pruchniewski Ł, Lewandowski K, Jarmuż-Szymczak M, Gil L. Adamska MM, et al. Among authors: czerwinska rybak j. Cent Eur J Immunol. 2021;46(4):524-530. doi: 10.5114/ceji.2021.111166. Epub 2021 Dec 12. Cent Eur J Immunol. 2021. PMID: 35125953 Free PMC article.
Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy.
Dytfeld D, Luczak M, Wrobel T, Usnarska-Zubkiewicz L, Brzezniakiewicz K, Jamroziak K, Giannopoulos K, Przybylowicz-Chalecka A, Ratajczak B, Czerwinska-Rybak J, Nowicki A, Joks M, Czechowska E, Zawartko M, Szczepaniak T, Grzasko N, Morawska M, Bochenek M, Kubicki T, Morawska M, Tusznio K, Jakubowiak A, Komarnicki MA. Dytfeld D, et al. Among authors: czerwinska rybak j. Oncotarget. 2016 Aug 30;7(35):56726-56736. doi: 10.18632/oncotarget.11059. Oncotarget. 2016. PMID: 27527861 Free PMC article.
Comparative proteomic profiling of sera from patients with refractory multiple myeloma reveals potential biomarkers predicting response to bortezomib-based therapy.
Łuczak M, Kubicki T, Rzetelska Z, Szczepaniak T, Przybyłowicz-Chalecka A, Ratajczak B, Czerwińska-Rybak J, Nowicki A, Joks M, Jakubowiak A, Komarnicki M, Dytfeld D. Łuczak M, et al. Among authors: czerwinska rybak j. Pol Arch Intern Med. 2017 Jun 30;127(6):392-400. doi: 10.20452/pamw.4032. Epub 2017 May 25. Pol Arch Intern Med. 2017. PMID: 28546528 Free article.
Translocation t(8;14)(q24;q11) with concurrent PTEN alterations and deletions of STIL/TAL1 and CDKN2A/B in a pediatric case of acute T-lymphoblastic leukemia: A genetic profile associated with adverse prognosis.
Skalska-Sadowska J, Dawidowska M, Szarzyńska-Zawadzka B, Jarmuż-Szymczak M, Czerwińska-Rybak J, Machowska L, Derwich K. Skalska-Sadowska J, et al. Among authors: czerwinska rybak j. Pediatr Blood Cancer. 2017 Apr;64(4). doi: 10.1002/pbc.26266. Epub 2016 Oct 19. Pediatr Blood Cancer. 2017. PMID: 27759908